In humans, activation of the TF TAL1, normally expressed early in the erythroid lineage, has been shown to alter a core transcriptional regulatory circuit that in turn leads to tumor onset (T cell leukemia) (Bradner et al., 2017). The gene discussed is TAL1; the disease is neoplasm.